NEUROTRIALS is the early clinical development unit of the ICM: a “one shop CRO” (Contract Research Organization) dedicated to the Proof Of Concept trials (Ib/IIa) exclusively on CNS diseases for drugs and medical devices.
Pioneers in Europe, NEUROTRIALS offers operational excellence in designing, running and delivering Proof Of Confidence studies in the area of CNS. In addition to bring access to Academic, Scientific and Medical excellence of the Brain and Spine Institute (ICM), this unit is committed to deliver clinical studies on time, within budget and with top-notch quality (industrial standards).
NEUROTRIALS works closely with the Clinical Investigation Centre (CIC) in Neurosciences of the Pitié-salpêtrière hospital (over 70 ongoing trials in neuroscience with more than 2000 visits per year).
The main investigated disorders are: Amyotrophic Lateral Sclerosis, Parkinson’s disease, Huntington’s disease, Dystonia, other movement disorders, Alzheimer’s disease, Frontotemporal Lobar degenerations, other dementias, Prion diseases, Multiple Sclerosis, Neuro-Oncology, Epilepsy, Autism, Depression, Tourette syndrome, Sleep disorders.